Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ·Healthcare·Biotechnology
$16.78
—
Mkt Cap $1.54B
Analyst Ratings
Buy
27
Hold
7
Sell
0
Price Target (67 analysts)
$26.25
Range $16.00 – $39.00
Implied Upside
+56.4%
Consensus $26.25 vs current $16.78
NASDAQ·Healthcare·Biotechnology
$16.78
—
Mkt Cap $1.54B
Buy
27
Hold
7
Sell
0
Price Target (67 analysts)
$26.25
Range $16.00 – $39.00
+56.4%
Consensus $26.25 vs current $16.78